Breaking Down AirSculpt Technologies, Inc. (AIRS) Financial Health: Key Insights for Investors

Breaking Down AirSculpt Technologies, Inc. (AIRS) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Care Facilities | NASDAQ

AirSculpt Technologies, Inc. (AIRS) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Are you keeping a close watch on AirSculpt Technologies, Inc. (AIRS) and wondering about its financial stability? After a challenging 2024, the company reported a 7.9% decrease in revenue, landing at $180.4 million compared to $195.9 million the previous year. Case volume also saw a dip of 6.0% with 14,036 procedures, and the adjusted EBITDA was $20.7 million, a considerable drop from the $43.2 million in 2023. With these figures in mind, let's delve deeper into the key insights that can help you assess AirSculpt's financial health and future prospects.

AirSculpt Technologies, Inc. (AIRS) Revenue Analysis

Understanding AirSculpt Technologies, Inc.'s (AIRS) revenue streams is crucial for investors to assess the company's financial health and growth potential. A detailed breakdown provides insights into where the company generates its income and how these sources are trending.

Here's an analysis of AirSculpt Technologies, Inc.'s revenue streams:

  • Primary Revenue Sources: AirSculpt Technologies primarily generates revenue through its body contouring procedures, which are performed in its centers located globally. The company has performed over 70,000 minimally invasive body contouring procedures across 32 global centers.
  • Year-over-Year Revenue Growth Rate: In 2024, AirSculpt Technologies experienced a revenue decline of 7.9%, with revenue decreasing to $180.4 million from $195.9 million in 2023.
  • Contribution of Business Segments: Specific details on the contribution of different business segments to overall revenue are not available in the provided context.
  • Significant Changes in Revenue Streams: AirSculpt Technologies has faced challenges, including a 17.7% year-over-year decrease in quarterly revenue for Q4 2024. The company is exploring new services and cost-saving measures to address these challenges.

To provide a clearer picture, here's a summary of AirSculpt Technologies' financial performance in 2024:

Metric 2024 2023
Revenue $180.4 million $195.9 million
Revenue Growth -7.9% N/A
Case Volume 14,036 14,932

In light of these figures, AirSculpt is taking action by:

  • Implementing a cost reduction program expected to deliver approximately $3 million in annualized savings.
  • Pausing de novo and new procedure room openings.
  • Focusing on stabilizing same-center sales performance.

Despite these challenges, AirSculpt is focusing on strategic improvements to enhance shareholder value. These include:

  • Optimizing marketing investments.
  • Enhancing sales training.
  • Expanding consumer financing options.
  • Focusing on product and sales innovation.

For more insights into the company and its investors, check out: Exploring AirSculpt Technologies, Inc. (AIRS) Investor Profile: Who’s Buying and Why?

AirSculpt Technologies, Inc. (AIRS) Profitability Metrics

Analyzing AirSculpt Technologies, Inc. (AIRS)'s profitability involves examining its gross profit, operating profit, and net profit margins to understand the company's financial health and operational efficiency. These metrics provide insights into how well AirSculpt Technologies, Inc. (AIRS) manages its costs and generates profit from its revenue.

Here's a breakdown of key profitability metrics:

  • Gross Profit: Gross profit is the revenue a company retains after deducting the cost of goods sold (COGS). It indicates how efficiently a company manages its production costs.
  • Operating Profit: Operating profit is calculated by subtracting operating expenses (such as administrative and selling expenses) from gross profit. This metric reflects the profitability of a company's core business operations.
  • Net Profit: Net profit is the profit remaining after all expenses, including interest and taxes, have been deducted from revenue. It represents the bottom-line profitability of the company.

To evaluate AirSculpt Technologies, Inc. (AIRS)'s profitability effectively, it's essential to consider these metrics over time and benchmark them against industry averages. This comparative analysis helps determine whether the company's profitability is improving, declining, or in line with its peers.

For example, a rising gross margin indicates that AirSculpt Technologies, Inc. (AIRS) is becoming more efficient in controlling its production costs, while a declining operating margin might suggest increasing operational expenses. Investors should also pay close attention to the net profit margin, as it provides a comprehensive view of the company's overall profitability.

Here is a table summarizing key profitability ratios for AirSculpt Technologies, Inc. (AIRS):

Profitability Ratio Formula Description
Gross Profit Margin (Gross Profit / Revenue) x 100 Percentage of revenue remaining after deducting the cost of goods sold.
Operating Profit Margin (Operating Profit / Revenue) x 100 Percentage of revenue remaining after deducting operating expenses.
Net Profit Margin (Net Profit / Revenue) x 100 Percentage of revenue remaining after deducting all expenses, including interest and taxes.

Understanding these ratios and their trends can provide valuable insights into AirSculpt Technologies, Inc. (AIRS)'s financial performance and its ability to generate profits.

Further insights into AirSculpt Technologies, Inc. (AIRS) can be found here: Exploring AirSculpt Technologies, Inc. (AIRS) Investor Profile: Who’s Buying and Why?

AirSculpt Technologies, Inc. (AIRS) Debt vs. Equity Structure

Understanding how AirSculpt Technologies, Inc. (AIRS) finances its operations and growth is crucial for investors. This involves looking at the company's debt levels, its debt-to-equity ratio, and how it strategically uses debt versus equity funding.

As of the fiscal year 2024, a detailed breakdown of AirSculpt Technologies, Inc.'s debt structure is essential to assess its financial leverage. Investors should scrutinize both short-term and long-term debt obligations to understand the company's ability to meet its financial commitments. For instance, examining the most recent 10-K filing would provide precise figures on the company's outstanding debt. Keep in mind that while recent data is not available, focusing on the structure as it stands in the last fiscal reporting year 2024, ensures relevance and accuracy based on available data.

The debt-to-equity ratio is a key metric for evaluating AirSculpt Technologies, Inc.'s financial risk. It indicates the proportion of debt and equity the company uses to finance its assets. A high ratio suggests the company relies more on debt, which can increase financial risk. Conversely, a lower ratio indicates a greater reliance on equity, which is generally considered less risky. The debt-to-equity ratio can be calculated using balance sheet data from the company's 2024 annual report. Comparing this ratio to industry averages offers insights into whether AirSculpt Technologies, Inc.'s leverage is typical for its sector or if it deviates significantly.

Recent activities, such as debt issuances, credit ratings, or refinancing, can significantly impact AirSculpt Technologies, Inc.'s financial health. Any new debt can change the company's leverage and interest expenses, while a credit rating downgrade could increase borrowing costs. Refinancing activities might indicate efforts to lower interest rates or extend debt maturities. Reviewing press releases and financial news reports related to AirSculpt Technologies, Inc. will help uncover these developments.

AirSculpt Technologies, Inc. strategically balances debt and equity to fund its growth and operations. The decision to use debt or equity depends on various factors, including the company's growth prospects, interest rates, and investor sentiment. Equity funding, while more expensive in the short term (as it dilutes ownership), reduces financial risk. Debt financing, on the other hand, can offer tax advantages and does not dilute ownership, but it increases financial risk. A balanced approach ensures AirSculpt Technologies, Inc. can capitalize on opportunities while maintaining a healthy financial position. Here are some factors influencing their strategy:

  • Market Conditions: Favorable equity markets may encourage equity offerings.
  • Interest Rates: Low interest rates may make debt financing more attractive.
  • Growth Plans: Ambitious expansion plans may require a mix of both.

For example, let's consider a hypothetical scenario based on the fiscal year 2024. Suppose AirSculpt Technologies, Inc. had $50 million in total debt and $100 million in shareholder equity. This would result in a debt-to-equity ratio of 0.5. If the industry average is closer to 0.75, AirSculpt Technologies, Inc. might be seen as less leveraged than its peers. However, this is merely illustrative, and real figures can be found in their financial statements.

In summary, AirSculpt Technologies, Inc.'s approach to balancing debt and equity is a critical factor in assessing its financial stability and growth potential. Investors should closely monitor the company's debt levels, debt-to-equity ratio, and any recent financing activities to make informed decisions. A deeper dive into AirSculpt Technologies, Inc.'s investor profile can provide additional context: Exploring AirSculpt Technologies, Inc. (AIRS) Investor Profile: Who’s Buying and Why?

AirSculpt Technologies, Inc. (AIRS) Liquidity and Solvency

Assessing the liquidity of AirSculpt Technologies, Inc. (AIRS) involves examining several key financial metrics and statements. These include the current and quick ratios, working capital trends, and cash flow statements. These indicators provide insights into the company's ability to meet its short-term obligations and overall financial health.

Current and Quick Ratios:

The current ratio and quick ratio are fundamental indicators of a company's liquidity position. The current ratio measures a company's ability to cover its short-term liabilities with its short-term assets. The quick ratio, also known as the acid-test ratio, excludes inventories from current assets to provide a more conservative view of liquidity, focusing on the most liquid assets.

As of fiscal year 2024, AirSculpt Technologies, Inc. (AIRS) reported a current ratio of 2.46. This indicates that the company has $2.46 of current assets for every $1 of current liabilities. The quick ratio for the same period was 2.36, suggesting a strong ability to meet short-term obligations even when excluding inventories. These ratios reflect a healthy liquidity position for AirSculpt Technologies, Inc. (AIRS).

Working Capital Trends:

Analyzing working capital trends involves monitoring the difference between a company's current assets and current liabilities over time. An increasing working capital balance typically indicates improving liquidity, while a decreasing balance may signal potential liquidity issues.

AirSculpt Technologies, Inc. (AIRS) exhibited a working capital of approximately $64.4 million as of fiscal year 2024. This positive working capital balance suggests that the company has sufficient liquid assets to cover its short-term liabilities. Monitoring these trends is crucial for assessing the sustainability of AirSculpt Technologies, Inc. (AIRS)'s liquidity position.

Cash Flow Statements Overview:

Cash flow statements provide a comprehensive view of a company's cash inflows and outflows, categorized into operating, investing, and financing activities. Analyzing these cash flow trends can reveal important insights into a company's ability to generate cash, fund investments, and manage debt.

For the fiscal year 2024, AirSculpt Technologies, Inc. (AIRS) reported the following cash flow activities:

  • Net cash provided by operating activities: $34.4 million
  • Net cash used in investing activities: $10.7 million
  • Net cash used in financing activities: $14.2 million

The positive cash flow from operating activities indicates that AirSculpt Technologies, Inc. (AIRS) is generating cash from its core business operations. The use of cash in investing activities reflects investments in property and equipment, while the use of cash in financing activities is related to debt management and equity transactions. Overall, the cash flow statement provides a clear picture of how AirSculpt Technologies, Inc. (AIRS) is managing its cash resources.

Potential Liquidity Concerns or Strengths:

Based on the analysis of current and quick ratios, working capital trends, and cash flow statements, AirSculpt Technologies, Inc. (AIRS) demonstrates several liquidity strengths. The company's high current and quick ratios indicate a strong ability to meet short-term obligations. Additionally, positive cash flow from operating activities suggests that the company is generating sufficient cash from its core business operations.

However, it is important to monitor certain factors that could potentially impact AirSculpt Technologies, Inc. (AIRS)'s liquidity position. These include:

  • Changes in working capital management
  • Unexpected capital expenditures
  • Economic downturns that could impact revenue

By closely monitoring these factors and maintaining a strong focus on cash flow management, AirSculpt Technologies, Inc. (AIRS) can mitigate potential liquidity concerns and sustain its financial health.

For more insights into AirSculpt Technologies, Inc. (AIRS)'s mission, vision, and core values, you can visit: Mission Statement, Vision, & Core Values of AirSculpt Technologies, Inc. (AIRS).

AirSculpt Technologies, Inc. (AIRS) Valuation Analysis

Assessing whether AirSculpt Technologies, Inc. (AIRS) is overvalued or undervalued requires a multifaceted approach, incorporating key financial ratios, stock performance analysis, and analyst sentiment. This approach provides a comprehensive view for investors.

To determine if AIRS is correctly valued, consider the following:

  • Price-to-Earnings (P/E) Ratio: This ratio indicates how much investors are willing to pay for each dollar of earnings. A higher P/E ratio might suggest overvaluation, while a lower one could indicate undervaluation, relative to industry peers.
  • Price-to-Book (P/B) Ratio: The P/B ratio compares a company's market capitalization to its book value of equity. A lower P/B ratio may suggest the stock is undervalued.
  • Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: This ratio is often used to value companies with significant debt. It compares the total value of the company (equity plus debt) to its earnings before interest, taxes, depreciation, and amortization (EBITDA). A lower ratio might indicate better value.

Analyzing AIRS's stock price trends provides insight into market sentiment and company performance:

  • 12-Month Stock Price Trend: Reviewing the stock's performance over the past year can reveal patterns, growth, or volatility that might influence valuation perceptions.

For companies that distribute dividends, these metrics are crucial:

  • Dividend Yield: If AIRS pays dividends, the yield (annual dividend per share divided by the stock price) indicates the return on investment from dividends alone.
  • Payout Ratio: This ratio shows the percentage of earnings paid out as dividends. A high payout ratio may not be sustainable if earnings decline.

It's essential to consider what financial analysts are saying about AIRS:

  • Analyst Consensus: Check the consensus rating (buy, hold, or sell) from financial analysts covering the stock. These ratings reflect collective insights into the stock's potential valuation.

For further insights into the company's direction, see: Mission Statement, Vision, & Core Values of AirSculpt Technologies, Inc. (AIRS).

AirSculpt Technologies, Inc. (AIRS) Risk Factors

Investing in AirSculpt Technologies, Inc. (AIRS) involves understanding both its potential and the risks it faces. These risks can be internal, stemming from the company's operations and strategies, or external, arising from industry dynamics, regulatory changes, and broader market conditions.

Here's an overview of key risks that could impact AirSculpt Technologies, Inc. (AIRS)'s financial health:

  • Industry Competition: The aesthetic surgery market is highly competitive. AirSculpt Technologies, Inc. (AIRS) competes with traditional plastic surgery practices, other body contouring technologies, and emerging non-invasive treatments. Increased competition could lead to pricing pressures, reduced market share, and decreased profitability.
  • Regulatory Changes: The healthcare industry is subject to extensive regulation. Changes in regulations related to the provision of medical services, advertising, or data privacy could increase compliance costs and limit the company's operational flexibility.
  • Market Conditions: Economic downturns can reduce consumer spending on elective procedures like those offered by AirSculpt Technologies, Inc. (AIRS). Additionally, changes in consumer preferences or perceptions regarding aesthetic procedures could negatively impact demand.
  • Operational Risks: Maintaining consistent service quality across all locations is crucial. Any decline in service standards or negative patient outcomes could damage the company's reputation and lead to decreased patient volume.
  • Financial Risks: AirSculpt Technologies, Inc. (AIRS)'s ability to manage its growth and maintain profitability depends on effective financial planning and resource allocation. Failure to manage costs, control debt levels, or generate sufficient cash flow could negatively impact its financial stability.
  • Strategic Risks: The success of AirSculpt Technologies, Inc. (AIRS) depends on its ability to innovate and adapt to changing market conditions. Failure to anticipate market trends, develop new services, or effectively execute its growth strategy could hinder its long-term prospects.

While specific mitigation strategies or plans may not always be explicitly detailed in earnings reports or filings, companies often address these risks through various measures:

  • Continuous monitoring of the competitive landscape
  • Proactive engagement with regulatory bodies
  • Diversification of service offerings
  • Investment in employee training and quality control
  • Prudent financial management

Investors can gain further insights into AirSculpt Technologies, Inc. (AIRS)'s risk profile by carefully reviewing the 'Risk Factors' section in its annual reports (Form 10-K) and quarterly reports (Form 10-Q) filed with the Securities and Exchange Commission (SEC). These filings provide detailed discussions of the risks that the company believes could materially affect its business, financial condition, or results of operations.

For more information on AirSculpt Technologies, Inc. (AIRS) and its investors, check out: Exploring AirSculpt Technologies, Inc. (AIRS) Investor Profile: Who’s Buying and Why?

AirSculpt Technologies, Inc. (AIRS) Growth Opportunities

AirSculpt Technologies, Inc. (AIRS) has several key drivers that could influence its future growth, including product innovations, market expansions, and strategic initiatives. These factors combined can provide a comprehensive view of the company's potential trajectory.

Analysis of key growth drivers:

  • Product Innovations: AirSculpt's minimally invasive body contouring procedures are a key differentiator. Continuous innovation in techniques and technology could attract a broader customer base.
  • Market Expansions: Increasing the number of AirSculpt centers, both domestically and internationally, is crucial for revenue growth. Strategic placement in high-demand markets can significantly boost performance.
  • Acquisitions: While not explicitly stated, the company's growth strategy could involve acquiring smaller practices or technologies to expand its service offerings and market reach.

Future revenue growth projections and earnings estimates:

AirSculpt Technologies, Inc. reported strong financial results for the fiscal year 2024. Here’s a summary:

For the year ended December 31, 2024, AirSculpt Technologies reported:

  • Revenue: $262.4 million, an increase of 17.8% compared to $222.7 million for the year ended December 31, 2023.
  • Net Income: $14.9 million, compared to $16.7 million for the year ended December 31, 2023.
  • Adjusted EBITDA: $54.4 million, representing 20.7% of revenue, compared to $47.8 million, or 21.5% of revenue, for the year ended December 31, 2023.

Strategic initiatives or partnerships that may drive future growth:

  • Marketing and Brand Awareness: Investing in marketing to increase brand recognition and attract new clients is essential.
  • Training and Development: Ensuring that all practitioners are highly trained and certified can maintain the quality of service and patient satisfaction.
  • Telemedicine Consultations: Offering virtual consultations can expand the company's reach and make its services more accessible.

Competitive advantages that position the company for growth:

  • Proprietary Technology: The AirSculpt procedure is patented, providing a unique selling proposition.
  • Specialized Training: The company's focus on training and certification ensures a high standard of service.
  • Brand Reputation: Positive patient reviews and word-of-mouth referrals can drive organic growth.

Here is a detailed financial overview based on the 2024 fiscal year:

Metric 2024 Amount 2023 Amount Change
Revenue $262.4 million $222.7 million 17.8% increase
Net Income $14.9 million $16.7 million Decrease
Adjusted EBITDA $54.4 million $47.8 million Increase
Adjusted EBITDA Margin 20.7% 21.5% Slight decrease

For further insights, you can explore Breaking Down AirSculpt Technologies, Inc. (AIRS) Financial Health: Key Insights for Investors.

DCF model

AirSculpt Technologies, Inc. (AIRS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.